Emory Eye Center retina specialist Daniel F. Martin, MD was the recent winner of the Richard and Hinda Rosenthal Foundation Award in the Visual Sciences through the Macula Society. The Society met in late February in Las Vegas, where Dr. Martin presented the Rosenthal Lecture, as this year's winner of the prestigious award.
The Rosenthal award is presented yearly to "that individual or group of individuals under 45 years of age whose work gives high promise of a notable advance in the clinical treatment of disorders of the eye." Dr. Martin joins a prestigious list of retina physicians who have won this award since its inception in 1991, the highest award bestowed upon retinal specialists in that age category.
"This distinguished award is presented to younger ophthalmologists who have made extremely important accomplishments in their career," says Thomas M. Aaberg, Sr., MD, director of Emory Eye Center. "We are very proud that Dan Martin, one of our own, was this year's worthy recipient of the Rosenthal Award."
Dr. Martin, the Thomas M. Aaberg Professor of Ophthalmology and Director of the Retina Service at Emory Eye Center, completed medical school at The Johns Hopkins University School of Medicine, followed by residency and chief residency in ophthalmology at Emory University School of Medicine. He completed a fellowship in Vitreoretinal Surgery and Diseases at Duke University Eye Center, followed by a two-year fellowship in Uveitis and Ocular Immunology at the National Eye Institute.
Dr. Martin's primary academic interests have been in the development of new therapies for retinal disease. He has been involved in the design, development, and execution of numerous clinical trials, having served as principal investigator for more than 20 studies, including AREDS (Age-Related Eye Disease Study), SOCA (Studies of Ocular Complications of AIDS) and numerous AMD (age-related macular degeneration) and diabetes trials. Additionally, he has served on numerous clinical trials committees, including three Data and Safety Monitoring Boards and five steering committees. Finally, he has served as the study chairman for six national randomized clinical trials. Dr. Martin pioneered the use of the ganciclovir implant and later valganciclovir for the treatment of CMV retinitis and led the clinical trials that resulted in FDA approval of both of these drugs.
He has published more than 60 peer-reviewed articles and has delivered more than 120 invited lectures. In 2002, Dr. Martin coordinated a public macular degeneration symposium at The Carter Center, which drew in more than 400 participants from the Atlanta area and as far away as Florida.
He serves on numerous committees for the American Academy of Ophthalmology, the Macula Society, the Georgia Society of Ophthalmology, The Emory Clinic, and the Emory Eye Center.
Dr. Martin and his family reside in Atlanta (30307).